Amid a heightened volume of health scams, this quiz may help determine your risk of falling for one. (New York Times) Pfizer ...

Cartoonist and counterculture icon R. Crumb reflects on his remarkable life and work in a new interview from his home in the South of France.

“For many years, the standard of care for ASHL was based on the RATHL trial, where newly diagnosed patients were given two cycles of ABVD [doxorubicin, bleomycin, vinblastine, and dacarbazine] and ...

Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.

The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.

For one, interest rates are finally going down, with the Federal Reserve executing its latest cut on December 10. And ...

The Nasdaq recovered on Tuesday to close higher while the S&P 500 and the Dow closed lower, impacted by declines in ...

Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

The following is the transcript of the interview with former FDA commissioner Scott Gottlieb, who now serves on the boards of Pfizer and United Healthcare, that aired on "Face the Nation with Margaret ...